Liquidia

LQDA

Tags: US Healthcare Biotechnology

Liquidia Technologies Price (LQDA)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

64,993,476

(6.6186)%

Market Cap of Liquidia (LQDA)

Market cap:

As of , LQDA has a market cap of . This makes LQDA the 1897th most valuable company in the US by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $8.26-16.99
Market Cap 1.25B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Dr. Roger A. Jeffs Ph.D.
IPO Date: July, 26, 2018
Country: US
Currency: USD
Headquaters: Morrisville, NC
Employees: 145

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: